Maxcyte (MXCT) Operating Margin (2020 - 2026)
Maxcyte's (MXCT) quarterly Operating Margin came in at 140.72% in Q2 2026, up 2652.0% year-over-year from 5.11% in Q2 2025, and down 119.58% quarter-over-quarter from 64.09% in Q1 2026.
Powered by 
Analysis
Maxcyte (MXCT) Operating Margin (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Operating Margin for 7 consecutive years, with 140.72% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Margin rose 2652.0% year-over-year to 140.72% in Q2 2026; TTM through Jun 2026 was 134.59%, a 1498.0% increase from a year earlier, with the FY2025 full-year figure at 157.14%, down 2460.0% from the prior year.
- Operating Margin was 140.72% for Q2 2026 at Maxcyte, down from 64.09% in the prior quarter.
- Over five years, Operating Margin peaked at 35.89% in Q1 2022 and troughed at 207.19% in Q3 2025.
- A 5-year average of 120.71% and a median of 129.53% in 2025 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin soared 6223 bps in 2022 and plunged 11777 bps in 2023, its largest moves.
- Over 5 years, Operating Margin stood at 54.34% in 2022, then grew by 5 bps to 51.68% in 2023, then tumbled by 187 bps to 148.41% in 2024, then retreated by 4 bps to 153.78% in 2025, then gained by 8 bps to 140.72% in 2026.
- The last three Operating Margin figures came in at 140.72% (Q2 2026), 64.09% (Q1 2026), and 153.78% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.12 Bn | 221.06 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 144.34 Bn | 139.99 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 41.01 Bn | 39.25 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 31.14 Bn | 29.97 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 13.89 Bn | 12.86 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 10.13 Bn | 8.51 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.34 Bn | 8.33 Bn | 110.04 Mn | 6.85% |
| 9 | 10x Genomics | 8.67 Bn | 8.12 Bn | 112.50 Mn | -12.95% |
| 10 | Maxcyte | 132.99 Mn | 132.99 Mn | 5.60 Mn | -140.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -140.72% |
| Mar 31, 2026 | -64.09% |
| Dec 31, 2025 | -153.78% |
| Sep 30, 2025 | -207.19% |
| Jun 30, 2025 | -167.24% |
| Mar 31, 2025 | -118.33% |
| Dec 31, 2024 | -148.41% |
| Sep 30, 2024 | -172.13% |
| Jun 30, 2024 | -114.76% |
| Mar 31, 2024 | -108.23% |
| Dec 31, 2023 | -51.68% |
| Sep 30, 2023 | -174.31% |
| Jun 30, 2023 | -144.56% |
| Mar 31, 2023 | -153.66% |
| Dec 31, 2022 | -54.34% |
| Sep 30, 2022 | -72.46% |
| Jun 30, 2022 | -90.96% |
| Mar 31, 2022 | -35.89% |
| Dec 31, 2021 | -48.81% |
| Sep 30, 2021 | -24.09% |